久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • FDA Expands Indication for Soliqua? 100/33 americanpharmaceuticalreview
    March 01, 2019
    The U.S. Food and Drug Administration (FDA) has approved the expanded use of Soliqua? 100/33 (insulin glargine and lixisenatide injection) 100 Units/mL and 33 mcg/mL.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service